| id | C00001721 |
|---|---|
| Name | alpha-Ergocryptine |
| CAS RN | 511-09-1 |
| Standard InChI | InChI=1S/C32H41N5O5/c1-17(2)12-25-29(39)36-11-7-10-26(36)32(41)37(25)30(40)31(42-32,18(3)4)34-28(38)20-13-22-21-8-6-9-23-27(21)19(15-33-23)14-24(22)35(5)16-20/h6,8-9,13,15,17-18,20,24-26,33,41H,7,10-12,14,16H2,1-5H3,(H,34,38)/t20-,24-,25+,26+,31-,32+/m1/s1 |
| Standard InChI (Main Layer) | InChI=1S/C32H41N5O5/c1-17(2)12-25-29(39)36-11-7-10-26(36)32(41)37(25)30(40)31(42-32,18(3)4)34-28(38)20-13-22-21-8-6-9-23-27(21)19(15-33-23)14-24(22)35(5)16-20/h6,8-9,13,15,17-18,20,24-26,33,41H,7,10-12,14,16H2,1-5H3,(H,34,38) |
| Phytochemical cluster | No. 4 |
|---|---|
| KCF-S cluster | No. 271 |
| By standard InChI | CHEMBL1403281 |
|---|---|
| By standard InChI Main Layer | CHEMBL1324934 CHEMBL1355095 CHEMBL1361596 CHEMBL1403281 |
| By LinkDB | C07545 |
|---|
| By CAS RN | C100269 |
|---|
| class name | count |
|---|
| family name | count |
|---|---|
| Clavicipitaceae | 2 |
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Claviceps grohii | 89176 | Clavicipitaceae | Fungi | |
| Claviceps purpurea | 5111 | Clavicipitaceae | Fungi |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1324934 |
CHEMBL1741321
(1)
|
1 / 0 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL1361596 |
CHEMBL1738312
(1)
|
0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | CHEMBL1361596 |
CHEMBL2114784
(1)
|
1 / 1 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL1403281 |
CHEMBL1794499
(1)
|
2 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL1361596 |
CHEMBL1614076
(1)
|
1 / 1 |
| P29466 | Caspase-1 | C14 | CHEMBL1324934 CHEMBL1403281 |
CHEMBL1614158
(2)
|
0 / 0 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL1361596 CHEMBL1403281 |
CHEMBL1794585
(2)
|
0 / 0 |
| O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL1324934 CHEMBL1361596 CHEMBL1403281 |
CHEMBL1614331
(1)
CHEMBL1614474
(2)
|
0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | CHEMBL1324934 |
CHEMBL1614544
(1)
|
11 / 10 |
| P08183 | Multidrug resistance protein 1 | drug | CHEMBL1403281 |
CHEMBL2076229
(1)
CHEMBL2076230
(1)
|
1 / 0 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1324934 CHEMBL1355095 |
CHEMBL1614027
(1)
CHEMBL1741325
(1)
|
0 / 1 |
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL1361596 |
CHEMBL1614166
(1)
|
1 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL1324934 CHEMBL1403281 |
CHEMBL1794311
(2)
|
2 / 3 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL1324934 CHEMBL1361596 CHEMBL1403281 |
CHEMBL1614458
(4)
|
0 / 0 |
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | CHEMBL1361596 CHEMBL1403281 |
CHEMBL1794495
(2)
|
2 / 2 |
| Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL1324934 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | CHEMBL1403281 |
CHEMBL1794486
(1)
|
0 / 0 |
| O75496 | Geminin | Unclassified protein | CHEMBL1361596 CHEMBL1403281 |
CHEMBL2114780
(2)
|
0 / 0 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL1361596 CHEMBL1324934 CHEMBL1403281 |
CHEMBL1614257
(1)
CHEMBL1614410
(1)
CHEMBL1614531 (3) |
1 / 3 |
| Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | CHEMBL1403281 |
CHEMBL1794342
(1)
|
0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL1324934 |
CHEMBL1794467
(1)
|
0 / 0 |
| Q99816 | Tumor susceptibility gene 101 protein | Unclassified protein | CHEMBL1361596 CHEMBL1403281 |
CHEMBL1738574
(2)
CHEMBL2114927
(2)
|
0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1324934 |
CHEMBL1741322
(1)
|
0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL1324934 CHEMBL1355095 CHEMBL1403281 |
CHEMBL1613910
(2)
CHEMBL1614227
(1)
|
3 / 3 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL1324934 CHEMBL1361596 CHEMBL1403281 |
CHEMBL1614038
(3)
|
2 / 2 |
| P55210 | Caspase-7 | C14 | CHEMBL1324934 CHEMBL1403281 |
CHEMBL1613779
(2)
|
0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1324934 CHEMBL1355095 |
CHEMBL1613777
(1)
CHEMBL1741323
(1)
|
1 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1324934 CHEMBL1403281 |
CHEMBL1614108
(2)
CHEMBL1613886
(2)
CHEMBL1741324 (1) |
0 / 1 |
| Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL1361596 CHEMBL1403281 |
CHEMBL1794483
(2)
|
0 / 0 |
| Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | CHEMBL1361596 |
CHEMBL1614052
(1)
|
1 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL1361596 CHEMBL1403281 |
CHEMBL1737991
(2)
|
0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL1324934 CHEMBL1361596 CHEMBL1403281 |
CHEMBL1614211
(3)
|
0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL1361596 CHEMBL1403281 |
CHEMBL1614250
(3)
CHEMBL1614421
(3)
CHEMBL1614502 (3) |
4 / 3 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL1403281 |
CHEMBL1738184
(1)
|
0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL1403281 |
CHEMBL1794536
(1)
|
0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL1324934 CHEMBL1361596 CHEMBL1403281 |
CHEMBL1613914
(3)
|
0 / 0 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL1324934 CHEMBL1361596 |
CHEMBL1613829
(2)
|
0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL1324934 CHEMBL1361596 CHEMBL1403281 |
CHEMBL1738442
(3)
|
0 / 0 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | CHEMBL1403281 |
CHEMBL1963966
(1)
|
0 / 0 |
| O00255 | Menin | Unclassified protein | CHEMBL1324934 CHEMBL1361596 CHEMBL1403281 |
CHEMBL1614257
(1)
CHEMBL1614531
(3)
|
2 / 5 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL1324934 CHEMBL1361596 CHEMBL1403281 |
CHEMBL1738090
(2)
CHEMBL1613933
(4)
CHEMBL1737904 (2) CHEMBL1738444 (2) |
0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL1324934 CHEMBL1361596 CHEMBL1403281 |
CHEMBL1738090
(2)
CHEMBL1613933
(4)
CHEMBL1737904 (2) CHEMBL1738444 (2) |
1 / 6 |
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| C100269 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | ergocryptine results in increased activity of CASP3 protein |
increases activity
|
protein |
21295106
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
| #257200 | Niemann-pick disease, type a |
P17405
|
| #607616 | Niemann-pick disease, type b |
P17405
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #172700 | Pick disease of brain |
P10636
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
| H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|